A temporary increase in type 1 diabetes diagnoses after infection or vaccination
A temporary increase in type 1 diabetes diagnoses after infection or vaccination A recent study conducted in Sweden reveals that type 1 diabetes diagnoses experienced a temporary increase within 30 days following a SARS-CoV-2 infection or a first dose of the COVID-19 vaccine. This observation applies to both children and adults, but it does not persist beyond this initial period.
The study analyzed data from over 9.5 million people, including 2.6 million children and 6.8 million adults, over a period from January 2020 to December 2023. The results show that the risk of developing type 1 diabetes was multiplied by 5.4 in children and by 3.3 in adults within 30 days following an infection. However, this risk returned to normal after this period, suggesting that the infection does not increase long-term risk but may instead accelerate diagnosis in individuals already in the early stages of the disease.
Type 1 diabetes is an autoimmune disease where the immune system destroys insulin-producing cells in the pancreas. Symptoms include excessive thirst, unexplained weight loss, and intense fatigue. Without treatment, this disease can lead to serious complications.
Regarding vaccination, researchers did not observe a lasting effect on the risk of type 1 diabetes. In children, a slight reduction in risk was noted after vaccination, but this disappeared when the analysis was restricted to adolescents aged 12 to 17. In adults, a slight excess risk was detected within 30 days following the first dose, but it was not confirmed after subsequent doses.
These findings indicate that the increase in diagnoses is likely related to earlier detection rather than a direct causal effect of the infection or vaccination. Respiratory infections like COVID-19 often lead to medical consultations where blood tests are performed, which can reveal preexisting but undiagnosed diabetes. Additionally, the infection can cause acute metabolic stress, accelerating the onset of symptoms in already predisposed individuals.
Researchers emphasize that these observations do not call into question the importance of COVID-19 vaccination. Instead, they highlight the need to monitor type 1 diabetes symptoms after an infection or vaccination to enable early diagnosis and treatment.
A temporary increase in type 1 diabetes diagnoses after infection or vaccination A recent study conducted in Sweden reveals that type 1 diabetes diagnoses experienced a temporary increase within 30 days following a SARS-CoV-2 infection or a first dose of the COVID-19 vaccine. This observation applies to both children and adults, but it does not persist beyond this initial period.
The study analyzed data from over 9.5 million people, including 2.6 million children and 6.8 million adults, over a period from January 2020 to December 2023. The results show that the risk of developing type 1 diabetes was multiplied by 5.4 in children and by 3.3 in adults within 30 days following an infection. However, this risk returned to normal after this period, suggesting that the infection does not increase long-term risk but may instead accelerate diagnosis in individuals already in the early stages of the disease.
Type 1 diabetes is an autoimmune disease where the immune system destroys insulin-producing cells in the pancreas. Symptoms include excessive thirst, unexplained weight loss, and intense fatigue.
Regarding vaccination, researchers did not observe a lasting effect on the risk of type 1 diabetes. In children, a slight reduction in risk was noted after vaccination, but this disappeared when the analysis was restricted to adolescents aged 12 to 17. In adults, a slight excess risk was detected within 30 days following the first dose, but it was not confirmed after subsequent doses.
These findings indicate that the increase in diagnoses is likely related to earlier detection rather than a direct causal effect of the infection or vaccination. Respiratory infections like COVID-19 often lead to medical consultations where blood tests are performed, which can reveal preexisting but undiagnosed diabetes. Additionally, the infection can cause acute metabolic stress, accelerating the onset of symptoms in already predisposed individuals.
Legal Attributions
Study Citation
DOI: https://doi.org/10.1007/s00125-026-06767-6
Title: SARS-CoV-2 infection and COVID-19 vaccination and the risk for new-onset type 1 diabetes: a register-based population study in Sweden
Journal: Diabetologia
Publisher: Springer Science and Business Media LLC
Authors: Huiqi Li; Lisa Morris; Maria Bygdell; Ailiana Santosa; Elin Allansson Kjölhede; Katarina Eeg-Olofsson; Fredrik Nyberg; Yiyi Xu